Help us to develop and prepare MRI as an ALS biomarker
Closed for enrollment
Study Name
CALSNIC-2 (Canadian ALS Neuroimaging Consortium)
PI
Michael Benatar, MD, PhD
Study Type
Observational, Cohort, Biomarker
Eligible Population
- Affected: Individuals affected with ALS or a related neurodegenerative disorder, including ALS-FTD, PLS, and PMA.
- Controls: Healthy controls 40 – 80 years old.
Study Purpose/Goals
To investigate, in a multi-center fashion, the usefulness of advancing magnetic resonance imaging (MRI) techniques as potential biomarkers for ALS
Procedures/Participation
3 half-day study visits in Miami over an 8-month period
- Brief family and medical history review
- MRI Scan
- Neuropsychological Testing
- Speech Testing
- Neurological Exam (Affected Participants only)
- Breathing Testing (Affected Participants only)
Contact
Join our family - together, we can change the course of this disease.
Join our family
Together, we can change the course of this disease.
ALS Treatment
About Us
Copyright © 2020. ALS Center at the University of Miami. All Rights Reserved. Branding by Mok2